#ASCO20

Nathan A. Pennell MD, PhD, FASCO

I messed up my poster so attaching slides here (Abstract 9529: A model comparing the value of broad next-gen sequencing (NGS)-based testing to single gene testing (SGT) in patients with

Dr. Kelly Shanahan

#ASCO20 #bcsm @OncoAlert Let's talk for a sec about "tolerable" TRAEs. Every time I see a report with a laundry list of AEs like diarrhea, rash, myalgia, neutropenia, anemia, etc,

Thoughts on the impact of SOLO2 - olaparib maintenance in recurrent #BRCA mutant #ovariancancer - this randomized trial demonstrated an overall survival benefit in this population - the first trial

Time to dive into #ASCO20 abstracts! High vegetable protein intake associated w/lower risk of breast cancer incidence & post dx death; higher animal protein intake associated w/higher risk of br

Nathan A. Pennell MD, PhD, FASCO

THREAD: I have heard a lot of self-righteous indignation about how we would be bankrupting the system with adjuvant targeted treatment for EGFR mutation+ NSCLC pts, so let's take a

Vk

$ARVN no additional responses from abstract, denominator goes up to 22. 2/20 responses for 10% PSA50 response (for evaluable patients)PR and deck don’t mention anything about AR degradation No info

Mike Thompson, MD, PhD, FASCO

1/ [THREAD] Timeline @ASCO Social Media & Analyses [Updated: May 22, 2020] #socialoncology #socpharm #ASCO20 #ASCO20 Tweeps -- remember to Report (& Block) SPAMmers using oncology hashtags. Clean

LBA4 @ASCO #ASCO20 plenary session: Thierry Andre presents the results of KEYNOTE-177 (Pembro vs. CTX) in MSI/dMMR #crcsm : Doubling of PFS w. Prembro (. vs . months - HR